
O. Reg. 884/93: DESIGNATED DRUGS
under Midwifery Act, 1991, S.O. 1991, c. 31
Skip to contentcurrent | January 22, 2010 – (e-Laws currency date) |
August 26, 2004 – January 21, 2010 | |
December 31, 1993 – August 25, 2004 |
Midwifery Act, 1991
Loi de 1991 sur les sages-femmes
ONTARIO REGULATION 884/93
DESIGNATED DRUGS
Consolidation Period: From January 22, 2010 to the e-Laws currency date.
Last amendment: 13/10.
Legislative History: 269/04, 13/10, CTR 9 JA 13 - 1, CTR 9 JA 13 – 2.
This Regulation is made in English only.
1. For the purposes of paragraph 5 of section 4 of the Act, the following substances are designated as substances that a member may administer by injection on the member’s own responsibility:
Ampicillin — for the purpose of preventing neonatal group B streptococcal disease
Bupivacaine — for the purpose of local anaesthesia for episiotomy or the repair of tears
Carbetocin
Carboprost tromethamine
Cefazolin — for the purpose of preventing neonatal group B streptococcal disease
Chloroprocaine — for the purpose of local anaesthesia for episiotomy or the repair of tears
Clindamycin — for the purpose of preventing neonatal group B streptococcal disease
Dimenhydrinate
Diphenhydramine hydrochloride
Epinephrine hydrochloride
Ergonovine maleate
Erythromycin — for the purpose of preventing neonatal group B streptococcal disease
Hepatitis B immune globulin
Hepatitis B vaccine
Intravenous fluids
Lidocaine hydrochloride with or without epinephrine — for the purpose of local anaesthesia for episiotomy or the repair of tears
Measles-mumps-rubella virus vaccine
Oxytocin
Penicillin G — for the purpose of preventing neonatal group B streptococcal disease
Phytonadione
RhD immune globulin
Varicella Zoster immune globulin
O. Reg. 13/10, s. 1.
2. For the purposes of paragraph 5 of section 4 of the Act, the following substances are designated as substances that a member may administer by inhalation on the member’s own responsibility:
Nitrous oxide
Therapeutic oxygen
O. Reg. 884/93, s. 2.
3. For the purposes of paragraph 6 of section 4 of the Act, the following drugs are designated as drugs that a member may prescribe on the member’s own responsibility:
Amoxicillin-clavulanic acid — for the purpose of treating mastitis
Cephalexin — for the purpose of treating mastitis
Ciprofloxacin (oral)
Clotrimazole
Clindamycin (oral)
Cloxacillin (oral)
Diclofenac (oral)
Domperidone — for the purpose of promoting lactation
Doxylamine succinate-pyridoxine hydrochloride
Ergonovine maleate (oral)
Erythromycin ophthalmic ointment
Folic acid (oral; greater than 1mg/dose)
Hepatitis B immune globulin
Hepatitis B vaccine
Hydrocortisone anorectal therapy compound
Metronidazole (oral)
Miconazole
Misoprostol — for the purpose of preventing postpartum hemorrhage
Mupirocin-betamethasone valerate-miconazole (topical)
Naproxen (oral)
Nitrofurantoin — for the purpose of treating urinary tract infections
Nystatin
Phytonadione
RhD immune globulin
Sulfamethoxazole-trimethoprim (oral)
Trimethoprim — for the purpose of treating urinary tract infections
O. Reg. 13/10, s. 2.
4. (1) In the course of engaging in the practice of midwifery, a member may use any drug on the order of a member of the College of Physicians and Surgeons of Ontario. O. Reg. 13/10, s. 3.
(2) For the purposes of paragraph 5 of section 4 of the Act, a member may administer any substance by injection or inhalation on the order of a member of the College of Physicians and Surgeons of Ontario. O. Reg. 13/10, s. 3.
5. A member may administer, prescribe or order any drug or substance that may lawfully be purchased or acquired without a prescription. O. Reg. 884/93, s. 5.
6. Omitted (provides for coming into force of provisions of this Regulation). O. Reg. 884/93, s. 6.